HAZAF yields 6.91% · MRK yields 2.76%● Live data
📍 HAZAF pulled ahead of the other in Year 1
Combined, HAZAF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HAZAF + MRK for your $10,000?
Hazama Ando Corporation engages in the construction and construction-related business in Japan and internationally. The company offers civil engineering and building construction services, including surveys, measurements, planning, designing, executing, supervising, technical guidance contract, commissioning, and consulting services. Its projects include offices, production and distribution facilities, medical and welfare facilities, educational and research facilities, cultural and sports facilities, commercial and leisure facilities, traditional facilities, housing complexes, and other buildings; and dams, water/sewer systems, tunnels, roads and land reclamation, bridges, airports, and other public works, as well as renewal, urban civil engineering, civil engineering structure, offshore engineering, and other projects. The company also provides real estate transaction services; and owns and uses real properties and securities. In addition, it undertakes soil survey and purification works, such as the collection, handling, and disposal of waste, as well as related consulting services; and offers planning, designing, and consulting services related to area and urban development, environmental improvements, etc. Further, the company is involved in power generation; and electricity, thermal, and other energy supply activities. Additionally, it sells construction materials, machinery, and appliances; develops, licenses, and sells software; and provides building maintenance and security services. The company was formerly known as Hazama Corporation and changed its name to Hazama Ando Corporation in April 2013. Hazama Ando Corporation was founded in 1873 and is headquartered in Tokyo, Japan.
Full HAZAF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.